US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Climb Bio, Inc. - Common Stock
(NQ:
CLYM
)
9.190
-0.090 (-0.97%)
Delayed Quote
Updated: 4:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Climb Bio, Inc. - Common Stock
< Previous
1
2
3
Next >
Climb Bio to Present at Upcoming Investor Conferences
October 31, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
October 15, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
October 11, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
October 04, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Climb Bio to Host Virtual Investor Event on October 15, 2024
October 03, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >